Eczema Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- The baby was born at the UZ Brussel maternity ward at 37 weeks of pregnancy or later
- The baby is in good health at the time of the initial check-up before the study begins
- The baby is between 1 and 14 days old at the time of joining the study
- The parent(s) or legal guardian(s) are able and willing to follow the study instructions throughout the trial
- The baby has been assessed as suitable for the study by the research team
- The parent(s) or legal guardian(s) are willing to avoid giving the baby any products containing probiotics from the first visit through to the last visit
- The parent(s) or legal guardian(s) have provided written consent for the baby to take part
Who may not be able to join:
- No parent or legal guardian is able to communicate in a local language used at the trial site
- The baby has a major condition present from birth (such as anal atresia or Down syndrome), or there is a suspicion of a long-term condition or illness (such as Hirschsprung's disease or a metabolic disorder)
- The baby has an immune system that does not work properly, either from birth or developed after birth
- The baby has had an infection at the time of the initial check-up or within the 7 days before it
- The baby has been admitted to the neonatal intensive care unit after birth
- The research team has assessed the baby as not suitable for the study for any other reason
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Koen Huysentruyt, Pediatric Gastroenterologist, Universitair Ziekenhuis Brussel
Phone: +32 02/476.37.17
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Peak measured crying time; The occurrence of infant colic at any time in the first 3 months of life.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.